Drug discovery has advanced into a highly complex and regulated process, requiring the seamless integration of biology, chemistry, and pharmacology. Over the past decades, the increasing demand for preclinical validation, clinical trials, and regulatory approvals has emphasized the need for more efficient analytical workflows.

Learn more

• Ashok Dongre, Senior Director & Head of Proteomics at Bristol-Myers Squibb

Uncover the power of precision in biopharmaceutical development with our upcoming webinar on Host Cell Protein (HCP) analysis. Join us to explore how Evosep’s technology is enabling researchers to meet stringent regulatory requirements by delivering reliable, high-sensitivity data.

Learn more

• Shawn Li, Principal Scientist at Merck
• Thomas Kofoed, Ph.D., Cofounder and CEO at Alphalyse

Looking to improve your lab’s efficiency and streamline your nLC-MS processes? Whether you’re new to Evosep or simply curious about how we can simplify your workflows, this session offers valuable insights for labs at all levels.

Learn more

• Gabriel Bracamontes, Product Specialist at Evosep
• Martin Thesbjerg, Laboratory Engineer at University of Aalborg

Whisper™ Zoom is designed to push the boundaries of sensitivity in proteomics, enabling you to work with even the most limited samples while maintaining high data quality. Join this webinar to learn more about our latest advencement for the Whisper Zoom methods, enabling sensitive and scalable workflows.

Learn more

• Pierre Sabatier, Researcher at Novo Nordisk Foundation Center for Protein Research, University of Copenhagen.
• Andrew Frey, Postdoctoral Research Associate at Newcastle University

Get an overview of Evosep latest innovation within robust, high-throughput proteomics and automated end-to-end workflows presented at HUPO 2024. Learn how Evosep’s approaches are driving new standards in efficiency, precision, and scalability for MS-based proteomics.

Learn more

• Mohammad Arefian, Postdoctoral Research Associate at Queen’s University Belfast
• Maico Lechner, PhD fellow at University of Copenhagen
• Marvin Thielert, Postdoc at Max Planck Institute for Biochemistry

On June 3rd at ASMS 2020, we launched EVOSEP+ which is a software and application addition to the Evosep One platform. The new set of methods extend the potential for clinical research.

Learn more

• Nicolai Bache, Head of Applications at Evosep
• Florian Meier, Junior Professor at Friedrich-Schiller-Universität Jena

Whisper is the latest Evosep One innovation that allow plug-and-play, split-free 100 nl/min performance. The new methods make use of Evosep’s unique low pressure gradient formation and very accurate flow control on the same standard system without technical modifications.

Learn more

• Nicolai Bache, Head of Applications at Evosep
• Andreas-David Brunner, PhD Student at Max Planck Institute

If you are new to our technology or just getting started this event is for you. We will introduce the basics of the Evosep One technology and include hot-from-the-lab data from our users.

Learn more

• Alexey Chernobrovkin, Senior Research Scientist at Pelago Bioscience
• Raja Nirujogi, Post Doc at University of Dundee

The global emergence of novel coronavirus disease 2019 (COVID-19) has underlined the requirement for rapid assays with high sensitivity and specificity for detection of infection and further to understand the molecular complexity of the disease.

Learn more

• Angela McArdle, Project Scientist at Cedars-Sinai
• Mathias Trost, Professor of Proteomics at Newcastle University

In Biopharmaceutical drug development and production, Host Cell Proteins are the left overs of the cells used to produce the therapeutic protein in the final formulation. Regulatory authorities have increased their demands on the amount of these proteins that can be found in the final drug to an absolute minimum.

Learn more

• Jiao Ma, PhD and Scientist II at AstraZeneca
• Anders Giessing, Senior Scientist at Novozymes

In this webinar we will explore the possibilities of using the Evosep One technology to perform protein-protein interaction analysis. Using very different approaches, both scientists will discuss their view on unravelling complex protein interactions.

Learn more

• Leonard Foster, Assistant Professor at University of British Columbia
• Lisa Jones, Associate Professor at University of Maryland

In the ever lasting effort to boost the number of protein identified in MS-based proteomic experiments, it has become clear that Data Independent Analysis (DIA), combined with short gradients, has become a winning combination.

Learn more

• Florian Meier, Junior professor at Friedrich Schiller University Jena
• Vadim Demichev, Project Research Scientist at the Francis Crick Institute

Proteomics analysis of human blood offers an attractive and challenging pipeline for discovery of biomarkers. Over the last few years the need for, large cohort, plasma analysis using proteomic techniques has become more and more prevalent for both discovery and targeted workflows.

Learn more

• Roman Fischer, Associate Professor and Head of Discovery Proteomics Facility at University of Oxford
• Lili Niu, Postdoc at University of Copenhagen

Explore the possibilities of using the Evosep One for targeted workflows. Michael MacCoss (University of Washington) and Vivian Delcourt (GIE-LCH) will share how they use the Evosep One for targeted workflows and a new method, specifically designed for hydrophobic compounds, will be presented.

Learn more

• Michael MacCoss Professor of Genome Sciences at University of Washington
• Vivian Delcourt, Ph.D. R&D Technical Manager at GIE-LCH, Laboratoire des Courses Hippiques

Drug discovery is the process through which potential new medicines are identified. It involves a wide range of scientific disciplines, including biology, chemistry and pharmacology.

Learn more

• Casimir Bamberger, PhD, Research Associate at The Scripps Research Institute
• Tanveer S. Batth, Assistant Professor at The Novo Nordisk Foundation Center for Protein Research

Automated sample prep workflows have gained in popularity in proteomics laboratories. In this webinar, users will share how they have standardized their sample prep workflows and discuss the advantages of combining automated sample prep workflows with the Evosep One.

Learn more

• Philipp E. Geyer, Co-founder & Managing Director at OmicEra Diagnostics GmbH
• Dorte Bekker-Jensen, Senior Scientist at Evosep

Formalin fixation and paraffin-embedded (FFPE) is the most common way to preserve clinical specimens and archived tissue banks represent a huge potential for protein biomarker studies. Proteins are stable in FFPE, but still challenging to extract for proteomics workflows.

Learn more

• Bernhard Kuster, Professor and Doctor at Technical University of Munich
• Lisa Schweizer, PhD Student at Max Planck Institute of Biochemistry

Whisper is the latest Evosep One innovation that allow plug-and-play, split-free 100 nl/min performance. The new methods make use of Evosep’s unique low pressure gradient formation and very accurate flow control on the same standard system without technical modifications.

Learn more

• Christoph Krisp, Applications Scientist at Bruker
• Angela Kruse, Postdoc at Vanderbilt University

If you are new to our technology or just getting started this event is for you. We will introduce the basics of the Evosep One technology and include hot-from-the-lab data from our users.

Learn more

• Ireshyn Govender, Application Specialist at Resyn Biosciences
• Felix Elortza, Proteomics Platform Manager at CIC Biogune

Clinical biochemistry laboratories worldwide measure millions of samples daily from various body fluids such as blood and urine. A growing part of these analyses are performed with LC-MS/MS and especially for diagnostic niches of laboratory medicine, where superior analytical specificity is superior to immunoassays.

Learn more

• Nicolai Jacob Wewer Albrechtsen, Associate Professor at University of Copenhagen
• Martin Overgaard, Biochemist at Odense University Hospital

In the ever lasting effort to boost the number of protein identified in MS-based proteomic experiments, it has become clear that Data Independent Analysis (DIA), combined with short gradients, has become a winning combination.

Learn more

• Patricia Skowronek, PhD Student at Max Planck Institute of Biochemistry
• Yves Le Blanc, Associate Chief Research Scientist at SCIEX
• Ihor Batruch, Technical Product Manager at SCIEX

Evotip Pure™ is a new generation Evotip developed for high performance. To ensure quality, we have internalized and refined all critical manufacturing and carefully chosen the chemistry.

Learn more

• Nicolai Bache, Head of Applications at Evosep
• Dorte Bekker-Jensen, Senior Scientist at Evosep

The development of antimicrobial resistance is limiting the number of antibiotics that can be used to successfully treat infections leaving a large proportion of all antimicrobials prescribed to human patients unnecessary.

Learn more

• Dimard Foudraine, Researcher at Erasmus MC, Medical Microbiology & Infectious Diseases
• Florence Roux Dalvai, Research Assistand at CHU Québec Laval University

Targeted workflows have gained in popularity, especially to detect established biomarkers for several applications. An increased focus, along with technological advancements is continuously pushing the limits for high-throughput targeted analysis.

Learn more

• Steve Sweet, Associate Director at AstraZeneca
• Konstantinos Kalogeropoulos, Scientist at DTU

Peptide fractionation is important in proteomics workflows to reduce sample complexity and increase the separation efficiency. This leads to increased dynamic range of the identified peptides compared to conventional single-shot analysis.

Learn more

• Claire Koenig, PhD Student at CPR
• Moritz Heusel, Senior Scientist at Evosep

Single cell proteomics is a field in rapid development, enabled by significant technological improvements over the last years and it presents a key contribution to answer fundamental biological questions about heterogeneity within complex systems.

Learn more

• Marvin Thielert, PHD Student at Max Planck Institute of Biochemistry
• Claudia Ctortecka, Postdoc at Broad Institute of MIT and Harvard

Get an overview of Evosep latest innovation within robust, high-throughput proteomics and automated end-to-end workflows presented at HUPO 2022.

Learn more

• Moritz Heusel, Senior Scientist at Evosep
• Dorte Bekker-Jensen, Senior Scientist at Evosep

If you are new to our technology or just getting started this event is for you. We will introduce the basics of the Evosep One technology and include hot-from-the-lab data from our users.

Learn more

• Nicolai Bache, Head of Applications at Evosep
• Allan Stensballe, Associate Professor at Aalborg University
• Theo Luider, Head of Laboratory Neuro-Oncology at Erasmus MC

Sepsis is a growing global challenge due to factors such as high mortality rate and the increasing prevalence of antimicrobial resistance. In this webinar we will uncover how our users combine technology with the Evosep One to further research into sepsis and its biomarkers.

Learn more

• Iulia Macavei, PhD student at University of Lyon

Unleash the power of DIA and enable the exploration of complex biological systems with unprecedented depth and precision for large-scale quantitative protein analysis combined with short methods on the Evosep One.

Learn more

• Anh Reynolds, Scientist at Bristol Myers Squibb
• Vadim Demichev, Group Leader at Charité – Universitätsmedizin Berlin

Targeted workflows are particularly interesting for identifying established biomarkers in various applications. The focus on these workflows, coupled with technological advancements, is continually expanding the boundaries of high-throughput targeted analysis.

Learn more

• Dr. Christoph Borchers at McGill University
• PhD. Anthony Maus, Clinical Mass Spec. Development Laboratory at Mayo Clinic

The use of high-throughput methods in plasma proteomics has revolutionized the field, allowing for the analysis of large cohorts of patients and the identification of hundreds or even thousands of proteins simultaneously. This approach has led to the discovery of novel biomarkers and therapeutic targets that were previously unknown.

Learn more

• Arthur Viodé, Proteomics Scientist at Boston Children’s Hospital
• Bharath Kumar Raghuraman, Post-doc at Odense University Hospital and Scientist at Evosep

Get an overview of all the highlights of Evosep at ASMS 2023, including brand-new insights, research, talks and much more from the conference!

Learn more

• Dorte Bekker-Jensen, Senior Scientist at Evosep

Immunopeptidomics is a field that combines proteomics and immunology to study the complex repertoire of peptides presented by major histocompatibility complex (MHC) molecules on the cell surface. Discover how the Evosep One accelerates discoveries, and support the understanding of immune responses and diseases.

Learn more

• Anthony Purcell, Professor at Purcell Lab, Monash University
• Kurt Boonen, Assistant Professor at University of Antwerp

Join us as we uncover how Evosep One empowers researchers to investigate the proteomic landscapes within single cells, paving the way for new discoveries and innovative therapeutic approaches.

Learn more

• Zilu Ye, Researcher at Olsen Group, Novo Nordisk Foundation Center for Protein Research
• Sophia Steigerwald, Researcher at Max planck institute of Biochemistry

This webinar is your guide to get started with a fast and efficient, automated sample preparation protocol on the Opentrons OT-2. Utilize protein aggregation capture (PAC) on magnetic microparticles in an end-to-end standardized and hands-off workflow, starting from protein lysate or plasma to peptide loaded on Evotips.

Learn more

• Anders H. Kverneland, MD & Postdoctoral Researcher at Herlev Hospital
• Dorte Bekker-Jensen, Application Manager at Evosep

Learn more about how the Evosep One has been used in identifying the proteins present in tumor tissues and discovering biomarkers used to detect or monitor the presence of cancer. These findings pave the way for translating research into clinical applications, including the development of new diagnostic tests, targeted therapies, and improved treatment protocols.

Learn more

• Roman Fischer, Associate Professor and Head of Discovery Proteomics Facility at University of Oxford
• Matthew Holt, Laboratory Director at Baylor College of Medicine

If you’re just beginning with our technology or are in the early stages of learning, this event is tailored for you. We’ll cover the fundamentals of the Evosep One technology, along with the latest, directly-from-the-lab data shared by our users.

Learn more

• Nicolai Bache, Head of Applications at Evosep
• Christina D. King, Scientist and Associate Director at Schilling Lab, Buck Institute

Explore the field of precision medicine with a focus on the critical role of transactional research. This webinar examines how these advancements are shaping medical practice and patient care.

Learn more

• Dr. Stephan Singer, Institute of Pathology at Universitätsklinikum Tübingen
• Professor Phil Robinson, Cell Signalling Unit at Children’s Medical Research Institute, Sydney

Join us for an in-depth look at the possibilities of using the Evosep One in proteomics core facilities, and how our technology offers er great fit when standardization and quality control are crucial to achieve reliable data.

Learn more

• Erik Soderblom, Director at Duke University
• Salla Keskitalo, PhD, Laboratory Chief at University of Helsinki

The adoption of high-throughput techniques in plasma proteomics has transformed the discipline by enabling the simultaneous analysis of large patient cohorts and the identification of hundreds to thousands of proteins. This strategy has facilitated the uncovering of new biomarkers and therapeutic targets that had not been identified before.

Learn more

• Boris Sarvin, VP Technology at MetaSight Diagnostics
• Stoyan Stoychev, Senior Scientist at Evosep & Head of Proteomics at ReSyn Biosciences

Now we are ready to scale up with Whisper™ Zoom. Our new and improved Whisper Flow Technology is a user-friendly set of methods that allows you to unlock the full potential of high-sensitivity applications.

Learn more

• Dr. Christoph Krisp, Application Development Specialist Proteomics at Bruker Daltonics
• Kristina Bennet Emdal, Assistant Professor at Novo Nordisk Foundation Center for Protein Research

Get an overview of our recent advancements to enhance the efficiency and accessibility of proteomics combined with scalable proteomics workflows. Dive into our fully automated workflows, the new Whisper Zoom methods, and the grand opening of Evosep Biolabs.

Learn more

• Pierre Camille Sabatier, Guest Researcher at Novo Nordisk Foundation Center for Protein Research
• Dorte Bekker-Jensen, Head of Application Development at Evosep

In this session, we explore how cutting-edge technology can detect the early signs of infectious disease with precision and speed. Early identification of disease markers can significantly enhance patient care by allowing for faster, more effective treatments.

Learn more

• PhD. Tony Hu, Center for Cellular & Molecular Diagnostics at Tulane Cancer Center
• Aaron Scott, PhD Student at Lund University